ロード中...

Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population

Multiple studies have demonstrated that obesity is associated with a worse outcome for all breast cancer subtypes and that obese breast cancer patients do not respond as well as normal weight patients to aromatase inhibitor treatment and chemotherapy. While a number of mechanisms have been proposed...

詳細記述

保存先:
書誌詳細
出版年:Curr Pharmacol Rep
主要な著者: Bowers, Laura W., deGraffenried, Linda A.
フォーマット: Artigo
言語:Inglês
出版事項: 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591549/
https://ncbi.nlm.nih.gov/pubmed/26442202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-015-0041-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!